Solel Partners’s CVS Health CVS Stock Holding History

Solel Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.08M	Sell	39,400 -454,300	-92%	-$40.6M	0.69%	20
2026 Q1	$35.5M	Sell	493,700 -100,000	-17%	-$7.7M	7.58%	5
2025 Q4	$47.1M	Sell	593,700 -120,000	-17%	-$9.46M	7.62%	3
2025 Q3	$53.8M	Buy	713,700 +39,400	+6%	+$2.7M	10.35%	3
2025 Q2	$46.5M	Sell	674,300 -100,000	-13%	-$6.56M	8.1%	5
2025 Q1	$52.5M	Sell	774,300 -650,100	-46%	-$38.9M	9.71%	3
2024 Q4	$63.9M	Buy	1,424,400 +295,500	+26%	+$16.6M	12.52%	2
2024 Q3	$71M	Buy	1,128,900 +625,500	+124%	+$36.5M	13.93%	1
2024 Q2	$29.7M	Buy	+503,400	New	+$31.5M	4.84%	12

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Solel Partners's CVS Position: Q2 2026 in Review

Solel Partners reduced its CVS Health (CVS) stake by 92% in Q2 2026, selling an estimated $40.6M and leaving 39,400 shares worth $4.08M. The position accounts for 0.69% of the portfolio, ranked #20.

Solel Partners first reported a position in CVS in Q2 2024 and has held it in 9 quarters since. The position peaked at $71M in Q3 2024. 2,066 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Solel Partners held 39,400 shares of CVS Health worth $4.08M as of Q2 2026.
Solel Partners sold 454,300 CVS Health shares in Q2 2026, an estimated $40.6M.
CVS Health made up 0.69% of Solel Partners's portfolio in Q2 2026, its #20 holding.
Solel Partners first reported a position in CVS Health in Q2 2024 and has held it in 9 quarters since.
Solel Partners's CVS Health position peaked at $71M in Q3 2024.
2,066 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Solel Partners's 13F filing for Q2 2026, filed 14 Aug 2026.